Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,361 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Elevation of Neutrophil-to-Lymphocyte Ratio before First-Line Chemotherapy Predicts a Poor Prognosis for Second-Line Chemotherapy in Gastric Cancer.
Inoue D, Sekiguchi S, Yamagata W, Maeda G, Yamada D, Fujiwara S, Itou S, Kurihara M, Hijioka Y, Shimoji K, Fujiki J, Nakazono A, Horike H, Yoshioka A, Ogura Y, Hatao F, Imamura K, Namiki S. Inoue D, et al. Among authors: fujiwara s. Oncology. 2019;96(3):140-146. doi: 10.1159/000493427. Epub 2018 Oct 26. Oncology. 2019. PMID: 30368510
Association of Soluble Interleukin-2 Receptor and C-Reactive Protein with the Efficacy of Bendamustine Salvage Treatment for Indolent Lymphomas and Mantle Cell Lymphoma.
Kawaguchi Y, Nakamaki T, Abe M, Baba Y, Murai S, Watanuki M, Arai N, Fujiwara S, Kabasawa N, Tsukamoto H, Uto Y, Ariizumi H, Yanagisawa K, Hattori N, Harada H, Saito B. Kawaguchi Y, et al. Among authors: fujiwara s. Acta Haematol. 2018;139(1):12-18. doi: 10.1159/000484711. Epub 2018 Jan 5. Acta Haematol. 2018. PMID: 29301121
Monitoring TIGIT/DNAM-1 and PVR/PVRL2 Immune Checkpoint Expression Levels in Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia.
Hattori N, Kawaguchi Y, Sasaki Y, Shimada S, Murai S, Abe M, Baba Y, Watanuki M, Fujiwara S, Arai N, Kabasawa N, Tsukamoto H, Uto Y, Yanagisawa K, Saito B, Harada H, Nakamaki T. Hattori N, et al. Among authors: fujiwara s. Biol Blood Marrow Transplant. 2019 May;25(5):861-867. doi: 10.1016/j.bbmt.2019.01.013. Epub 2019 Jan 11. Biol Blood Marrow Transplant. 2019. PMID: 30639819 Free article.
Comparative Study of Tacrolimus and Short-Term Methotrexate: 2-Day versus 3-Day Methotrexate as Graft-versus-Host-Disease Prophylaxis after Umbilical Cord Blood Transplantation in Adults.
Hattori N, Saito B, Matsui T, Nakata A, Sasaki Y, Shimada S, Murai S, Abe M, Baba Y, Watanuki M, Fujiwara S, Kawaguchi Y, Arai N, Kabasawa N, Tsukamoto H, Uto Y, Yanagisawa K, Harada H, Nakamaki T. Hattori N, et al. Among authors: fujiwara s. Biol Blood Marrow Transplant. 2020 Feb;26(2):367-372. doi: 10.1016/j.bbmt.2019.10.022. Epub 2019 Oct 31. Biol Blood Marrow Transplant. 2020. PMID: 31678538 Free article.
Status of Natural Killer Cell Recovery in Day 21 Bone Marrow after Allogeneic Hematopoietic Stem Cell Transplantation Predicts Clinical Outcome.
Hattori N, Saito B, Sasaki Y, Shimada S, Murai S, Abe M, Baba Y, Watanuki M, Fujiwara S, Kawaguchi Y, Arai N, Kabasawa N, Tsukamoto H, Uto Y, Ariizumi H, Yanagisawa K, Harada H, Nakamaki T. Hattori N, et al. Among authors: fujiwara s. Biol Blood Marrow Transplant. 2018 Sep;24(9):1841-1847. doi: 10.1016/j.bbmt.2018.05.007. Epub 2018 May 16. Biol Blood Marrow Transplant. 2018. PMID: 29753837 Free article.
Corrigendum to 'Comparative Study of Tacrolimus and Short-Term Methotrexate: 2-Day versus 3-Day Methotrexate as Graft-versus-Host-Disease Prophylaxis after Umbilical Cord Blood Transplantation in Adults' [Biology of Blood and Marrow Transplantation 26/2 (2020) 367-372].
Hattori N, Saito B, Matsui T, Nakata A, Sasaki Y, Shimada S, Murai S, Abe M, Baba Y, Watanuki M, Fujiwara S, Kawaguchi Y, Arai N, Kabasawa N, Tsukamoto H, Uto Y, Yanagisawa K, Harada H, Nakamaki T. Hattori N, et al. Among authors: fujiwara s. Transplant Cell Ther. 2022 Oct;28(10):720. doi: 10.1016/j.bbmt.2020.02.008. Epub 2020 Mar 12. Transplant Cell Ther. 2022. PMID: 32171657 Free article. No abstract available.
Refined Disease Risk Index for Hematological Malignancies, Including Rare Disorders, After Allogeneic Stem Cell Transplantation.
Fujiwara S, Hattori N, Matsui T, Nakata A, Sasaki Y, Shimada S, Murai S, Abe M, Baba Y, Watanuki M, Kawaguchi Y, Arai N, Kabasawa N, Tsukamoto H, Uto Y, Yanagisawa K, Harada H, Nakamaki T. Fujiwara S, et al. Transplant Proc. 2019 Dec;51(10):3437-3443. doi: 10.1016/j.transproceed.2019.08.044. Epub 2019 Nov 14. Transplant Proc. 2019. PMID: 31733801
Early relapse of severe chronic active Epstein-Barr virus infection with posterior reversible encephalopathy syndrome after reduced intensity stem cell transplantation with umbilical cord blood.
Hattori N, Yamamoto K, Kawaguchi Y, Fujiwara S, Arai N, Kabasawa N, Tsukamoto H, Uto Y, Yanagisawa K, Saito B, Nakamaki T. Hattori N, et al. Among authors: fujiwara s. Leuk Lymphoma. 2016 Oct;57(10):2448-51. doi: 10.3109/10428194.2016.1142081. Epub 2016 Feb 15. Leuk Lymphoma. 2016. PMID: 26879589 No abstract available.
Association of red cell distribution width with clinical outcomes in myelodysplastic syndrome.
Baba Y, Saito B, Shimada S, Sasaki Y, Murai S, Abe M, Fujiwara S, Arai N, Kawaguchi Y, Kabasawa N, Tsukamoto H, Uto Y, Ariizumi H, Yanagisawa K, Hattori N, Harada H, Nakamaki T. Baba Y, et al. Among authors: fujiwara s. Leuk Res. 2018 Apr;67:56-59. doi: 10.1016/j.leukres.2018.02.004. Epub 2018 Feb 7. Leuk Res. 2018. PMID: 29433052 Free article.
2,361 results